BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 886656)

  • 21. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 1-Sar-8-Ala-angiotensin II on systemic and pulmonary haemodynamics in hypertensive patients.
    Fagard R; Amery A; Lijnen P; Reybrouck T; Joossens JV; Billiet L; Moerman E; De Schaepdryver A
    Clin Exp Pharmacol Physiol; 1978; 5(5):457-64. PubMed ID: 729204
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma renin response to acute blockade of angiotensin II in the anaesthetized rat.
    Oates HF; Stokes GS; Glover RG
    Clin Exp Pharmacol Physiol; 1974; 1(2):155-60. PubMed ID: 4156503
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II blockade in patients with essential hypertension.
    MacGregor GA; Dawes PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):53-4. PubMed ID: 1071404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].
    Philipp T; Zschierdrich H; Distler A
    Klin Wochenschr; 1977 Sep; 55(18):917-9. PubMed ID: 916618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saralasin in human hypertension: the early experience.
    Brunner HR; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
    Van Hoogdalem P; Donker AJ; Leenen FH
    Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
    Fagard R; Amery A; Lijnen P; Reybrouck T
    Eur J Clin Pharmacol; 1977 Aug; 12(1):1-5. PubMed ID: 902672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the renin-angiotensin system in renal hypertension. An experimental approach.
    Helmchen U; Kneissler U
    Curr Top Pathol; 1976; 61():203-38. PubMed ID: 1248262
    [No Abstract]   [Full Text] [Related]  

  • 31. Outpatient experience with saralasin.
    Streeten DH; Anderson GH
    Kidney Int Suppl; 1979 Mar; (9):S44-52. PubMed ID: 289863
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
    Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
    Circulation; 1980 May; 61(5):920-4. PubMed ID: 6988103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;
    Streeten DH; Anderson GH; Freiberg JM; Dalakos TG
    N Engl J Med; 1975 Mar; 292(13):657-62. PubMed ID: 235090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors.
    Riegger AJ; Lever AF; Millar JA; Morton JJ; Slack B
    Lancet; 1977 Dec 24-31; 2(8052-8053):1317-9. PubMed ID: 74729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin, blood volume and response to saralasin in patients on chronic haemodialysis: evidence against volume- and renin-'dependent' hypertension.
    McGrath BP; Ledingham JG
    Clin Sci Mol Med; 1978 Mar; 54(3):305-12. PubMed ID: 630806
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the biological effects of two angiotensin II analogues in hypertensive patients with sodium depletion.
    Hata T; Ogihara T; Mikami H; Nakamaru M; Maruyama A; Mandai T; Kumahara Y
    Life Sci; 1978 Jun; 22(21):1955-62. PubMed ID: 672437
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiotensin II blockade in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):61-3. PubMed ID: 1071407
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
    Higuma K; Fujishima S; Shionoiri H; Tochikubo O; Uneda S; Fujiki Y; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiotensin blockade in renovascular hypertension: a controlled, prospective study.
    Marks LS; Maxwell MH; Gross C; Waks U; Kaufman JJ
    Br J Urol; 1977 Jun; 49(3):181-8. PubMed ID: 334316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.